Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sar131675 Exhibits Anticancer Activity on Human Ovarian Cancer Cells Through Inhibition of Vegfr-3/Erk1/2/Akt Signaling Pathway Publisher Pubmed



Babaei Z1, 2 ; Panjehpour M1 ; Parsian H3 ; Aghaei M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Clinical Biochemistry and Biophysics, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
  3. 3. Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran

Source: Cellular Signalling Published:2023


Abstract

Vascular endothelial growth factor receptor-3 (VEGFR-3) is known to participate in tumorigenesis and lymphangiogenesis, and as such, has the potential to serve as a molecular target for cancer therapy. SAR131675 is a highly selective VEGFR-3 antagonist that has an inhibitive effect on lymphatic cell growth. However, the anticancer effects and underlying mechanisms of SAR131675 in ovarian cancer remain poorly understood. In this study, we investigated the pathological role of VEGFR-3, and the effects of SAR131675 on proliferation, cell cycle, migration, and apoptosis in ovarian cancer cells. Our results showed that the mRNA and protein of VEGFR-3 were expressed in OVCAR3 and SKOV3 ovarian cancer cells, and this receptor was activated following stimulation with 50 ng/ml VEGF-C Cys156Ser (VEGF-CS), a selective ligand for VEGFR-3. Enhancing VEGFR-3 phosphorylation by treatment of ovarian cancer cells with VEGF-CS resulted in increased levels of phosphorylated extracellular signal-regulated kinases 1/2 (ERK1/2) and AKT. Moreover, our data demonstrated that SAR131675 inhibited VEGF-CS-mediated proliferation, colony formation, and migration of cancer cells in a dose-dependent manner. In addition, inhibition of VEGFR-3 activation with SAR131675 significantly increased cell cycle arrest and promoted apoptosis in both OVCAR3 and SKOV3 cells. Mechanistically, SAR131675 effectively suppressed the VEGF-CS-induced phosphorylation of VEGFR-3 and its downstream effectors including activated ERK1/2 and AKT in ovarian cancer cells. Our results reveal an anticancer activity of SAR131675 on the growth and migration of ovarian cancer cells, which may be through inhibiting VEGFR-3/ERK1/2/AKT pathway. SAR131675 may serve as an effective targeted drug for ovarian cancer. © 2023 Elsevier Inc.
Related Docs
View other Related Docs
1. Vegfr3 Suppression Through Mir-1236 Inhibits Proliferation and Induces Apoptosis in Ovarian Cancer Via Erk1/2 and Akt Signaling Pathways, Journal of Cellular Biochemistry (2023)
2. Molecular Mechanisms of Mir-1236 in the Assessment of Tumor Lymphangiogenesis in Human Ovarian Cancer Patients, Journal of Gene Medicine (2023)
3. Α2β1 Integrin Specific Inhibitor Btt-3033 Promotes Paclitaxel-Induced Apoptosis in Human Ovarian Cancer Cells, Research in Pharmaceutical Sciences (2024)
4. Sar131675 Receptor Tyrosine Kinase Inhibitor Induces Apoptosis Through Bcl-2/Bax/Cyto C Mitochondrial Pathway in Human Umbilical Vein Endothelial Cells, Anti-Cancer Agents in Medicinal Chemistry (2022)
5. Mir-1236: Key Controller of Tumor Development and Progression: Focus on the Biological Functions and Molecular Mechanisms, Pathology Research and Practice (2023)
6. Wnt7b As a Novel Candidate in Silico Analysis of Angiogenesis-Related Expressed Genes in Non-Small Cell Lung Cancer Patients, Iranian Journal of Blood and Cancer (2023)
7. Rhoa/Rock Pathway Mediates Leptin-Induced Upa Expression to Promote Cell Invasion in Ovarian Cancer Cells, Cellular Signalling (2017)
8. Acquired Tumor Resistance to Antiangiogenic Therapy: Mechanisms at a Glance, Journal of Research in Medical Sciences (2017)
Experts (# of related papers)
View all Related Experts
Mahmoud Aghaei (8)
Mojtaba Panjehpour (4)
Other Related Docs
9. Insulin-Like Growth Factor Binding Protein 3 Chemosensitizes Pancreatic Ductal Adenocarcinoma Through Its Death Receptor, Pancreatology (2020)
10. Au Nanoparticles in the Diagnosis and Treatment of Ovarian Cancer: A New Horizon in the Personalized Medicine, Nanomedicine Research Journal (2022)
11. In Vitro Evaluation of the Pogostone Effects on the Expression of Pten and Dact1 Tumor Suppressor Genes, Cell Cycle, and Apoptosis in Ovarian Cancer Cell Line, Research in Pharmaceutical Sciences (2022)
12. Exploiting New Strategies in Combating Head and Neck Carcinoma: A Comprehensive Review on Phytochemical Approaches Passing Through Pi3k/Akt/Mtor Signaling Pathway, Phytotherapy Research (2024)
13. Nf-Κb Pathway and Angiogenesis: Insights Into Colorectal Cancer Development and Therapeutic Targets, European journal of medical research (2024)
14. Evaluation of Endoglin As an Angiogenesis Marker in Glioblastoma, Iranian Journal of Pathology (2015)
15. Egfr As a Potential Target for the Treatment of Pancreatic Cancer: Dilemma and Controversies, Current Drug Targets (2014)
16. Induction of Humoral Immune Responses and Inhibition of Metastasis in Mice by a Vegf Peptide-Based Vaccine, Iranian Journal of Basic Medical Sciences (2020)
17. Clinicopathological Correlation of Insulin-Like Growth Factor Binding Protein 3 and Their Death Receptor in Patients With Gastric Cancer, Research in Pharmaceutical Sciences (2024)
18. Evaluation of the Relationship Between Cd163 Positive Macrophages and Prognostic Factors in Serous Ovarian Tumors, Immunopathologia Persa (2020)
19. Estrogen-Independent Role of Erα in Ovarian Cancer Progression Induced by Leptin/Ob-Rb Axis, Molecular and Cellular Biochemistry (2019)
20. Blockage of Hotair Reduced Cell Proliferation in Human Ovarian Cancer Cells Through Upregulation of Akt2, Indian Journal of Gynecologic Oncology (2019)
21. Synergistic Antitumor Effect of Nvp-Bez235 and Cape on Mda-Mb-231 Breast Cancer Cells, Biomedicine and Pharmacotherapy (2017)
22. Atorvastatin Enhances the Antitumor Activity of Tamoxifen in B16f10 Mouse Melanoma Cell Lines, Physiology and Pharmacology (Iran) (2021)
23. Lxr Inhibitor Sr9243-Loaded Immunoliposomes Modulate Lipid Metabolism and Stemness in Colorectal Cancer Cells, Medical Oncology (2023)
24. The Role of Lncrna Mcm3ap-As1 in Human Cancer, Clinical and Translational Oncology (2023)
25. Green Tea and Its Anti-Angiogenesis Effects, Biomedicine and Pharmacotherapy (2017)
26. Nephrotoxicity Induced by Vascular Endothelial Growth Factor Inhibitors, Journal of Nephropharmacology (2022)
27. Gdf15 Induced Apoptosis and Cytotoxicity in A549 Cells Depends on Tgfbr2 Expression, Cell Biochemistry and Function (2019)
28. Silibinin Exerts Anti-Cancer Activity on Human Ovarian Cancer Cells by Increasing Apoptosis and Inhibiting Epithelial-Mesenchymal Transition (Emt), Gene (2022)
29. The Interaction of Insulin-Like Growth Factor Binding Protein 3 (Igfbp-3) in Insulin-Like Growth Factor (Igf)-Independent System, Journal of Isfahan Medical School (2017)
30. Bioinformatic Designing for Producing Vaccine Peptide of Human Vascular Endothelial Growth Factor (Vegf-A), and Evaluation of Polyclonal Antibodies in Mice, Journal of Isfahan Medical School (2016)
31. The Role of Dapk2 As a Key Regulatory Element in Various Human Cancers: A Systematic Review, Molecular Biology Reports (2024)
32. Leptin Induces Matrix Metalloproteinase 7 Expression to Promote Ovarian Cancer Cell Invasion by Activating Erk and Jnk Pathways, Journal of Cellular Biochemistry (2018)
33. Small Extracellular Vesicle Tgf-Β in Cancer Progression and Immune Evasion, Cancer Gene Therapy (2023)
34. Microrna-30C-2-3P Regulates Er Stress and Induces Apoptosis in Ovarian Cancer Cells Underlying Er Stress, EXCLI Journal (2021)
35. Angiogenesis in Health and Disease: Role of Vascular Endothelial Growth Factor (Vegf), Journal of Isfahan Medical School (2011)
36. Signaling Pathways Governing Glioma Cancer Stem Cells Behavior, Cellular Signalling (2023)
37. The Role of Natural Products As Inhibitors of Jak/Stat Signaling Pathways in Glioblastoma Treatment, Oxidative Medicine and Cellular Longevity (2022)